Daytrana medication guide

First Page		Document Content
Transdermal patches Dosage forms Daytrana Attention-deficit hyperactivity disorder Methylphenidate Patch Eczema Pharmacology Medicine Pharmaceutical sciences		Daytrana medication guide Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 141,01 KB Share Document on Facebook

	PDF Document DocID: 1wNvE - View Document
	PDF Document DocID: 1wBpa - View Document
	Terms of Use Welcome to www.daytrana.com, a website owned by Noven Pharmaceuticals, Inc. This website is produced by Noven Therapeutics LLC. The information provided on this site is for general information and educationa DocID: 1v0Hj - View Document
	NOVEN PROVIDES UPDATE ON DAYTRANA® METHYLPHENIDATE TRANSDERMAL SYSTEM Shire Undertakes Non-Safety-Related Voluntary Market Withdrawal/Recall of a Limited Portion of Daytrana® Product Financial Reserve Established by No DocID: 1upp0 - View Document
	NOVEN TO ACQUIRE DAYTRANA® METHYLPHENIDATE TRANSDERMAL SYSTEM FROM SHIRE The First and Only Patch for ADHD to be Marketed and Sold by Noven Therapeutics Miami, FL, August 10, Noven Pharmaceuticals, Inc. today an DocID: 1ugJY - View Document